# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 623 results.
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
Status: Not yet recruiting
Last Changed: Jun 17, 2019
First Received: Jun 17, 2019
Disease(s): Acute Myeloid Leukemia
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Nov 27, 2017
First Received: Jun 22, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): NK Cells + Chemotherapy Starting
Locations: Centro Terapia e Tecnologia Celular, Porto Alegre, Rio Grande Do Sul, Brazil
SEL24/MEN1703 in Patients With Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Jul 30, 2019
First Received: Jan 02, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): SEL24/MEN1703
Locations: Northside Hospital, Atlanta, Georgia, United States
Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio, United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
... and 1 other locations.
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 06, 2019
First Received: Nov 29, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): Standard Leukemia Care, Palliative Care
Locations: Massachusetts general Hospital, Boston, Massachusetts, United States
Duke University, Durham, North Carolina, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Prognostic Values of Next Generation Sequencing (NGS) in Acute Myeloid Leukemia Patients With Allo-HSCT
Status: Not yet recruiting
Last Changed: Oct 23, 2018
First Received: Oct 23, 2018
Disease(s): Acute Myeloid Leukemia
Locations: The First affiliated Hospital of SooChow University, Suzhou, Jiangsu, China
Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Mar 01, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): prospective study on digestive affections in an homogeneous cohort of hematological patients
Locations: CHU Amiens-Picardie, Amiens, France
CHU de Caen, Caen, France
Henri Becquerel Center, Rouen, France
Lintuzumab-Ac225 in Combination With CLAG-M Chemotherapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 25, 2019
First Received: Feb 21, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Lintuzumab AC 225, Cladribine, Cytarabine, Mitoxantrone, G-csf
Locations: Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Recruiting
Last Changed: Feb 27, 2019
First Received: Feb 16, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): BST-236
Locations: Augusta University Georgia Cancer Center, Augusta, Georgia, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
Franciscan Physician Network Oncology and Hematology Specialists, Indianapolis, Indiana, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Memorial Sloan Kettering Cancer Center New York, New York, New York, United States
... and 12 other locations.
Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Aug 07, 2019
First Received: Apr 24, 2017
Disease(s): Relapsed Adult Acute Myeloid Leukemia, Refractory Adult Acute Myeloid Leukemia
Intervention(s): Merestinib, LY2874455
Locations: Brigham and Women's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Jun 07, 2019
First Received: Mar 30, 2018
Disease(s): Cancer - Acute Myeloid Leukemia
Intervention(s): Venetoclax, Dinaciclib
Locations: University of Arkansas /ID# 200016, Little Rock, Arkansas, United States
David Geffen School of Medicin /ID# 200015, Los Angeles, California, United States
Cedars-Sinai Medical Center - West Hollywood /ID# 202245, West Hollywood, California, United States
The University of Chicago /ID# 200017, Chicago, Illinois, United States
Univ Maryland School Medicine /ID# 204015, Baltimore, Maryland, United States
... and 10 other locations.